Back

Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: CMR LGE in ischaemic and nonischaemic disease Late Gadolinium Enhancement ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Kai Nogami

Mayo Clinic, Rochester (United States of America)

6 More presentations in this session

Presentation thumbnail
Cardiac magnetic resonance characterization and prediction of left ventricular thrombus after ST-segment elevation myocardial infarction
Doctor V. Marcos Garces (Valencia, ES)
Abstract Slides
Presentation thumbnail
Association between inflammation and left ventricular thrombus formation following ST-elevation myocardial infarction
Doctor M. Holzknecht (Innsbruck, AT)
Abstract Slides
Presentation thumbnail
Temporal trends and outcomes in ST-segment elevation myocardial infarction: a cardiac magnetic resonance imaging study over the course of 15 years
Doctor I. Lechner (Innsbruck, AT)
Abstract Slides
Presentation thumbnail
Association of late gadolinium enhancement in cardiac magnetic resonance with heart failure outcomes in patients with non-ischemic cardiomyopathy
Doctor M. Tao (Hartford, US)
Abstract Slides
Presentation thumbnail
Association of late-gadolinium enhancement in cardiac magnetic resonance with ventricular arrhythmias and mortality in patients with non-ischemic cardiomyopathy
Doctor F. Aslam (Stony Brook, US)
Abstract Slides

Access the full session

Session thumbnail
CMR LGE in ischaemic and nonischaemic disease

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
CMR in acute coronary syndrome: optional or essential? - discussion
thumbnail
Congress Presentation
Late gadolinium enhancement and viability
thumbnail
Congress Presentation
Magnetic resonance imaging is the way to go for risk assessment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources